Phytocompounds: An Alternative Antimicrobial Therapy and Beneficial Bioactive Molecules
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (15 March 2024) | Viewed by 442
Special Issue Editor
Interests: implant-associated infections; anti-infective substances and strategies; virulence factors; bacterial biofilm; bacterial molecular epidemiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antibiotic resistance has become a worldwide concern that requires constant surveillance. ESKAPE bacteria, for example, can “escape” the common antibiotic therapies due to their increasing drug resistances. Multidrug-resistant (MDR), extensively drug-resistant (XDR) and pan-drug-resistant (PDR) pathogens have emerged as a public health threat and they are a leading cause of life-threatening hospital-acquired infections. This worrying threat may be addressed with the help of phytocompounds, alone or in synergy with other natural or synthetic substances.
Moreover, phytocompounds have been showed to have other important properties favorable to the human health as antioxidant, anti-inflammatory, immunomodulating, wound healing and anticancer properties.
The innovation of nanotechnologies can be extended to the production of phytocompound nanosystems for the delivery of substances as well as to the application to biomaterials.
Those natural substances and nanosystems can be investigated through “in vitro” trials with the aim to prove their indicated assumptions.
Manuscript topics may include the following:
- Antimicrobial and antibiofilm assays.
- Cytotoxicity assays in human cells.
- Wound healing assays.
- Evaluation of anticancer and anti-inflammatory properties.
- Development of nanocarriers for the phytocompounds’ applications.
- Development of biomaterials including phytocompounds in nanosystems.
- “In vitro” trials to define the performances of phytocompounds in term of antimicrobial and healthy benefits.
Dr. Stefano Ravaioli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- phytocompounds
- antimicrobial and anti-biofilm activities
- synergistic effects
- ESKAPE pathogens
- anti-inflammatory, antioxidants, and anticancer activities
- wound healing properties
- bioactive molecules
- phytocompounds applications
- nanosystems
- “in vitro” trials
